MARKET

SNY

SNY

Sanofi FR
NASDAQ
47.72
-0.30
-0.62%
Pre Market: 48.37 +0.65 +1.36% 08:50 04/17 EDT
OPEN
47.84
PREV CLOSE
48.02
HIGH
47.94
LOW
47.41
VOLUME
25.67K
TURNOVER
0
52 WEEK HIGH
53.38
52 WEEK LOW
43.32
MARKET CAP
115.25B
P/E (TTM)
12.76
1D
5D
1M
3M
1Y
5Y
1D
Trump nominates Erica Schwartz to lead CDC, ending months-long search
Seeking Alpha · 5h ago
Trump names Erica Schwartz CDC Director
TipRanks · 17h ago
Trump Trade: White House launches space nuclear initiative
TipRanks · 21h ago
Drugmakers raised prices on hundreds of drugs, NBC News reports
TipRanks · 23h ago
Vir Biotechnology closes global collaboration agreement with Astellas Pharma
TipRanks · 23h ago
ClearBridge International Value Strategy expands holdings, trims portfolio in Q1
Seeking Alpha · 1d ago
DKSH partners with Sanofi to expand cardiovascular, diabetes treatment access in Southeast Asia
PUBT · 1d ago
Protalix: Elfabrio Struggles Against Oral Competition
Seeking Alpha · 1d ago
More
About SNY
Sanofi SA is a France-based healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme.

Webull offers Sanofi SA (ADR) stock information, including NASDAQ: SNY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SNY stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SNY stock methods without spending real money on the virtual paper trading platform.